DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Ignatiadis M, Litiere S, Rothe F. et al.
Trastuzumab versus observation for HER2 non amplified early breast cancer with Circulating Tumor Cells (EORTC90091-10093, BIG 1-12, Treat CTC): A randomized phase 2 trial.
Ann Oncol 2018;
DOI: 10.1093/annonc/mdy211.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.